0001236031-17-000022.txt : 20171106 0001236031-17-000022.hdr.sgml : 20171106 20171106130514 ACCESSION NUMBER: 0001236031-17-000022 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171102 FILED AS OF DATE: 20171106 DATE AS OF CHANGE: 20171106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KERSTEN GEERT R CENTRAL INDEX KEY: 0001236030 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11889 FILM NUMBER: 171178940 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CEL SCI CORP CENTRAL INDEX KEY: 0000725363 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 840916344 STATE OF INCORPORATION: CO FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 8229 BOONE BLVD . STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 BUSINESS PHONE: 7035069460 MAIL ADDRESS: STREET 1: 8229 BOONE BLVD. STREET 2: SUITE 802 CITY: VIENNA STATE: VA ZIP: 22182 FORMER COMPANY: FORMER CONFORMED NAME: INTERLEUKIN 2 INC DATE OF NAME CHANGE: 19880317 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-11-02 0 0000725363 CEL SCI CORP cvm 0001236030 KERSTEN GEERT R 1 1 0 0 Chief Executive Officer Series RR Warrants 1.65 2017-11-02 4 A 0 54585 0.01 A 2017-11-02 2022-10-30 Common Stock 54585 1031396 I Beneficiary Series RR Warrants 1.65 2017-11-02 4 A 0 73965 0.01 A 2017-11-02 2022-10-30 Common Stock 73965 1105361 D In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants. A trust in which Mr. Kersten holds a beneficial interest participated in the offering in July 2017. Geert Kersten 2017-11-06